Self-tolerance in a minimal model of the idiotypic network

Frontiers in Immunology

Volumn 5, Issue MAR, 2014, Pages

  Schulz, Robert ^a   Werner, Benjamin ^a,b   Behn, Ulrich ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b MAX PLANCK INSTITUTE FOR EVOLUTIONARY BIOLOGY   (Germany)

Author keywords

Autoimmunity; Bitstring model; Control of autoreactive idiotypes; Idiotypic network; Mean field theory; Self tolerance

Indexed keywords

IMMUNOGLOBULIN IDIOTYPE;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; BINDING SITE; CELL DEATH; CELL PROLIFERATION; HOMEOSTASIS; IMMUNE RESPONSE; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGICAL TOLERANCE; MATHEMATICAL ANALYSIS; MEAN FIELD THEORY; SIMULATION; THEORY;

EID: 84897950677     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00086     Document Type: Article

References (70)

1. Coutinho A. Beyond clonal selection and network. Immunol Rev (1989) 110(1):63-88. doi: 10.1111/j.1600-065X.1989.tb00027.x
2. Jerne NK. Towards a network theory of the immune system. Ann Immunol (1974) 125C:373-89.
3. Jerne NK. Idiotypic networks and other preconceived ideas. Immunol Rev (1984) 79(1):5-24. doi:10.1111/j.1600-065X.1984.tb00484.x
4. Jerne NK. The generative grammar of the immune system. EMBO J (1985) 4:847-52.
5. Sim GK, MacNeil IA, Augustin A. T helper cell receptors: idiotypes and repertoire. Immunol Rev (1986) 90:49-72. doi:10.1111/j.1600-065X.1986.tb01477.x
6. Huetz F, Jacquemart F, Peña Rossi C, Varela F, Coutinho A. Autoimmunity: the moving boundaries between physiology and pathology. J Autoimmun (1988) 1(6):507-18. doi:10.1016/0896-8411(88)90044-3
7. Varela FJ, Coutinho A. Second generation immune networks. Immunol Today (1991) 12(5):159-66. doi:10.1016/S0167-5699(05)80046-5
8. Coutinho A. A walk with Francisco Varela from first-to second-generation networks: in search of the structure, dynamics and metadynamics of an organism-centered immune system. Biol Res (2003) 36(1):17-26. doi:10.4067/S0716-97602003000100004
9. Urbain J, Wikler M, Franssen J, Collignon C. Idiotypic regulation of the immune system by the induction of antibodies against anti-idiotypic antibodies. Proc Natl Acad Sci U S A (1977) 74(11):5126-30. doi:10.1073/pnas.74.11.5126
10. Hampe CS. Protective role of anti-idiotypic antibodies in autoimmunity-lessons for type 1 diabetes. Autoimmunity (2012) 45(4):320-31. doi:10.3109/08916934.2012.659299
11. Avrameas S. Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. Immunol Today (1991) 12(5):154-9. doi:10.1016/0167-5699(91)90080-D
12. Shoenfeld Y, George J. Induction of autoimmunity. A role for the idiotypic network. Ann N Y Acad Sci (1997) 815:342-9. doi:10.1111/j.1749-6632.1997.tb52080.x
13. Shoenfeld Y. The idiotypic network in autoimmunity: antibodies that bind antibodies that bind antibodies. Nat Med (2004) 10(1):17-8. doi:10.1038/nm0104-17
14. Pendergraft WF, Preston GA, Shah RR, Tropsha A, Carter CW, Jennette JC, et al. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med (2003) 10(1):72-9. doi:10.1038/nm968
15. McGuire KL, Holmes DS. Role of complementary proteins in autoimmunity: an old idea re-emerges with new twists. Trends Immunol (2005) 26(7):367-72. doi:10.1016/j.it.2005.05.001
16. Tzioufas AG, Routsias JG. Idiotype, anti-idiotype network of autoantibodies. Autoimmun Rev (2010) 9(9):631-3. doi:10.1016/j.autrev.2010.05.013
17. Routsias JG, Tzioufas AG. B-cell epitopes of the intracellular autoantigens Ro/SSA and La/SSB: tools to study the regulation of the autoimmune response. J Autoimmun (2010) 35(3):256-64. doi:10.1016/j.jaut.2010.06.016
18. Dwyer DS, Vakil M, Kearney J. Idiotypic network connectivity and a possible cause of myasthenia gravis. J Exp Med (1986) 164(4):1310-8. doi:10.1084/jem.164.4.1310
19. Langman R, Cohn M. Editorial introduction. Semin Immunol (2000) 12(3):159-62. doi:10.1006/smim.2000.0227
20. Langman R, Cohn M. A minimal model for the self-nonself discrimination: a return to the basics. Semin Immunol (2000) 12(3):189-95. doi:10.1006/smim.2000.0231
21. Anderson CC, Matzinger P. Danger: the view from the bottom of the cliff. Semin Immunol (2000) 12(3):231-8. doi:10.1006/smim.2000.0236
22. Grossman Z, Paul WE. Self-tolerance: context dependent tuning of T cell antigen recognition. Semin Immunol (2000) 12(3):197-203. doi:10.1006/smim.2000.0232
23. Grossman Z, Paul WE. Autoreactivity, dynamic tuning and selectivity. Curr Opin Immunol (2001) 13(6):687-98. doi:10.1016/S0952-7915(01)00280-1
24. Grossman Z, Min B, Meier-Schellersheim M, Paul WE. Opinion: concomitant regulation of T-cell activation and homeostasis. Nat Rev Immunol (2004) 4(5):387-95. doi:10.1038/nri1355
25. Cohen I. Discrimination and dialogue in the immune system. Semin Immunol (2000) 12(3):215-9. doi:10.1006/smim.2000.0234
26. Cohen IR. Biomarkers, self-antigens and the immunological homunculus. J Autoimmun (2007) 29(4):246-9. doi:10.1016/j.jaut.2007.07.016
27. Poletaev AB, Stepanyuk VL, Gershwin EM. Integrating immunity: the immunculus and self-reactivity. J Autoimmun (2008) 30(1-2):68-73. doi:10.1016/j.jaut.2007.11.012
28. Zinkernagel R. Localization dose and time of antigens determine immune reactivity. Semin Immunol (2000) 12(3):163-71. doi:10.1006/smim.2000.0253
29. Sakaguchi S, Wing K, Miyara M. Regulatory T cells-a brief history and perspective. Eur J Immunol (2007) 37(S1):S116-23. doi:10.1002/eji.200737593
30. Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T. Regulatory T cells: how do they suppress immune responses? Int Immunol (2009) 21(10):1105-11. doi:10.1093/intimm/dxp095
31. Shoenfeld Y, Rose NR editors. Infection and Autoimmunity. Amsterdam: Elsevier (2004).
32. Vanderlugt CL, Miller SD. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat Rev Immunol (2002) 2(2):85-95. doi:10.1038/nri724
33. Meda F, Folci M, Baccarelli A, Selmi C. The epigenetics of autoimmunity. Cell Mol Immunol (2011) 8(3):226-36. doi:10.1038/cmi.2010.78
34. Zouali M editor. The Epigenetics of Autoimmune Diseases. Chichester: Wiley (2009).
35. Wucherpfennig KW, Noel RJ. Editorial overview. Curr Opin Immunol (2011) 23(6):699-701. doi:10.1016/j.coi.2011.10.003
36. Pillai S, Mattoo H, Cariappa A. B cells and autoimmunity. Curr Opin Immunol (2011) 23(6):721-31. doi:10.1016/j.coi.2011.10.007
37. Fagarasan S, Honjo T. T-independent immune response: new aspects of B cell biology. Science (2000) 290(5489):89-92. doi:10.1126/science.290.5489.89
38. Bogen B, Ruffini P. Review: to what extent are T cells tolerant to immunoglobulin variable regions? Scand J Immunol (2009) 70(6):526-30. doi:10.1111/j.1365-3083.2009.02340.x
39. Salinas GF, Braza F, Brouard S, Tak P-P, Baeten D. The role of B lymphocytes in the progression from autoimmunity to autoimmune disease. Clin Immunol (2013) 146(1):34-45. doi:10.1016/j.clim.2012.10.005
40. Stewart J, Varela FJ. Exploring the meaning of connectivity in the immune network. Immunol Rev (1989) 110:37-61. doi:10.1111/j.1600-065X.1989.tb00026.x
41. Kearney J, Vakil M, Nicholson A. Non-random VH gene expression and idiotype anti-idiotype expression in early B cells. In: Kelsoe G, Schulze D editors. Evolution and Vertebrate Immunity: The Antigen Receptor and MHC Gene Families. Austin: Texas University Press (1987). p. 175-90.
42. Stewart J, Varela FJ, Coutinho A. The relationship between connectivity and tolerance as revealed by computer simulation of the immune network: some lessons for an understanding of autoimmunity. J Autoimmun (1989) 2:15-23. doi:10.1016/0896-8411(89)90113-3
43. Sulzer B, van Hemmen JL, Behn U. Central immune system, the self and autoimmunity. Bull Math Biol (1994) 56(6):1009-40. doi:10.1016/S0092-8240(05)80331-3
44. Calenbuhr V, Varela F, Bersini H. Natural tolerance as a function of network connectivity. Int J Bifurcat Chaos (1996) 06(09):1691-702. doi:10.1142/S0218127496001041
45. De Boer RJ, Perelson AS. Size and connectivity as emergent properties of a developing immune network. J Theor Biol (1991) 149(3):381-424. doi:10.1016/S0022-5193(05)80313-3
46. Stewart J, Varela FJ. Morphogenesis in shape-space. Elementary meta-dynamics in a model of the immune network. J Theor Biol (1991) 153(4):477-98. doi:10.1016/S0022-5193(05)80152-3
47. Takumi K, De Boer RJ. Self assertion modeled as a network repertoire of multi-determinant antibodies. J Theor Biol (1996) 183:55-66. doi:10.1006/jtbi.1996.0201
48. Carneiro J, Coutinho A, Faro J, Stewart J. A model of the immune network with B-T cell co-operation. I-prototypical structures and dynamics. J Theor Biol (1996) 182(4):513-29. doi:10.1006/jtbi.1996.0193
49. Carneiro J, Coutinho A, Stewart J. A model of the immune network with B-T cell co-operation. II-the simulation of ontogenesis. J Theor Biol (1996) 182(4):531-47. doi:10.1006/jtbi.1996.0193
50. Leon K, Carneiro J, Perez R, Montero E, Lage A. Natural and induced tolerance in an immune network model. J Theor Biol (1998) 193(3):519-34. doi:10.1006/jtbi.1998.0720
51. Stewart J, Coutinho A. The affirmation of self: a new perspective on the immune system. Artif Life (2004) 10:261-76. doi:10.1162/1064546041255593
52. Behn U. Idiotypic networks: toward a renaissance? Immunol Rev (2007) 216(1):142-52. doi:10.1111/j.1600-065X.2006.00496.x
53. Behn U. Idiotype network. In: Delves P, editor. Encyclopedia of Life Sciences (ELS). Chichester: John Wiley & Sons, Ltd (2011). p. 1-11. doi:10.1002/9780470015902.a0000954.pub2
54. Bersini H. Self-assertion versus self-recognition: a tribute to Francisco Varela. In: Timmis J, Bentley PJ editors. Proceedings of the 1st International Conference on Artificial Immune Systems (ICARIS). Canterbury: University of Kent at Canterbury Printing Unit (2002). p. 107-112.
55. Vaz NM. Francisco Varela and the immunological self. Syst Res Behav Sci (2011) 28(6):696-703. doi:10.1002/sres.1126
56. Vaz NM. The specificity of immunologic observations. Construct Found (2011) 6(3):334-42. Available from: http://www.univie.ac.at/constructivism/journal/6/3/334.vaz
57. Vaz NM, Ramos GC, deCastro AB. The enactive paradigm 33 years later. Response to Alfred Tauber. Construct Found (2011) 6(3):345-51. Available from: http://www.univie.ac.at/constructivism/journal/6/3/345.vaz
58. Brede M, Behn U. Patterns in randomly evolving networks: idiotypic networks. Phys Rev E (2003) 67(3):031920. doi:10.1103/PhysRevE.67.031920
59. Schmidtchen H, Behn U. Randomly evolving idiotypic networks: analysis of building principles. In: Bersini H, Carneiro J editors. Artificial Immune Systems, Volume 4163 of Lecture Notes in Computer Science. Berlin: Springer (2006). p. 81-94.
60. Schmidtchen H, Thüne M, Behn U. Randomly evolving idiotypic networks: structural properties and architecture. Phys Rev E (2012) 86(1):011930. doi:10.1103/PhysRevE.86.011930
61. Schmidtchen H, Behn U. Randomly evolving idiotypic networks: modular mean field theory. Phys Rev E (2012) 86(1):011931. doi:10.1103/PhysRevE.86.011931
62. Berek C, Milstein C. The dynamic nature of the antibody repertoire. Immunol Rev (1988) 105:5-26. doi:10.1111/j.1600-065X.1988.tb00763.x
63. Perelson A, Weisbuch G. Immunology for physicists. Rev Mod Phys (1997) 69:1219. doi:10.1103/RevModPhys.69.1219
64. Sachsenweger H. Bitstring Model for the Idiotypic Network: Automatized Pattern Identification and Simulation of Large Systems. Master's thesis. Leipzig: University Leipzig, Institute for Theoretical Physics (2012).
65. Werner B. Idiotypische Netzwerke mit Antigenen: Gedächtnis und Selbsttoleranz. Diplomarbeit. Leipzig: University Leipzig, Institute for Theoretical Physics (2010).
66. Feldmann M, Steinman L. Design of effective immunotherapy for human autoimmunity. Nature (2005) 435(7042):612-9. doi:10.1038/nature03727
67. Chan AC, Carter PJ. Therapeutic antibodies for autoimmunity and inflammation. Nat Rev Immunol (2010) 10:301-16. doi:10.1038/nri2761
68. Cohen IR. Autoantibody repertoires, natural biomarkers, and system controllers. Trends Immunol (2013) 34(12):620-5. doi:10.1016/j.it.2013.05.003
69. Madi A, Kenett DY, Bransburg-Zabary S, Merbl Y, Quintana FJ, Tauber AI, et al. Network theory analysis of antibody-antigen reactivity data: the immune trees at birth and adulthood. PLoS One (2011) 6(3):e17445. doi:10.1371/journal.pone.0017445
70. Stafford P, Halperin R, Legutki JB, Magee DM, Galgiani J, Johnston SA. Physical characterization of the "immunosignaturing effect." Mol Cell Proteom (2012) 11(4):M111.011593. doi:10.1074/mcp.M111.011593